Patients with cirrhosis have an increased risk of dying from pneumococcal pneumonia. Their immunological response to pneumococcal vaccination is not known. We compared the antibody response to challenge with a 14-valent purified pneumococcal polysaccharide vaccine in 15 patients with biopsy-proven a
Implementation of Vaccination in Patients with Cirrhosis
โ Scribed by Miguel R. Arguedas; Brendan M. McGuire; Michael B. Fallon
- Book ID
- 110323607
- Publisher
- Springer US
- Year
- 2002
- Tongue
- English
- Weight
- 49 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0163-2116
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
In a 14-day multiple-dose study the pharmacokinetics of paroxetine was investigated in 12 patients with alcoholic cirrhosis and in 6 subjects without liver disease. The dose of 20-30 mg paroxetine daily was adjusted to the reduction in liver function, as assessed by the galactose elimination capacit
Plasma selenium concentration is decreased in patients with cirrhosis and, based on this finding, it has been suggested that patients with cirrhosis are selenium deficient. We measured plasma selenium concentration and the two plasma selenoproteins, glutathione peroxidase (GSHPx-3) and selenoprotein